Please provide your email address to receive an email when new articles are posted on . Shorter surgery-free survival was observed among patients on conventional therapy only in the pre-biologics era.
Real-world data show distinct determinants of health-related quality of life in Crohn’s disease and ulcerative colitis, ...
- ENTYVIO ® superior to Humira ® in achieving clinical remission and mucosal healing at week 52 in patients with moderately to severely active ulcerative colitis OAKVILLE, ON, March 11, 2019 /CNW/ - ...
Inflammatory bowel disease (IBD) is characterized by chronic intestinal inflammation. It is commonly treated with anti-inflammatory drugs, such as corticosteroids and biologics. Share on Pinterest ...
Crohn's disease is a serious inflammatory bowel disease (IBD) that impacts millions worldwide. The disease is chronic and highly unpredictable, manifesting symptoms such as abdominal pain, ...
After enduring years of severe gastrointestinal distress that made him want to stay home and close to a bathroom, Joseph Beinlich was diagnosed with ulcerative colitis in 2019. He was 11 years old. To ...
The 68-year-old patient had multiple myeloma and breast cancer. A new case report details a complete pathological response to a 3-month combination therapy of ixazomib, bendamustine, and dexamethasone ...
The incidence of inflammatory bowel disease (IBD) has risen significantly in recent decades, and some racial and ethnic minority groups have borne the brunt of that increase. Between 1970 and 2010, ...
Biological changes show up in blood tests in people with inflammatory bowel disease years before their diagnosis. Researchers used these findings to develop a way to predict whether someone may have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback